Insider Transactions in Q3 2020 at En V Veno Medical Corp (NVNO)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
75,000
-5.07%
|
$0
$0.38 P/Share
|
|
Aug 20
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
75,000
-4.82%
|
$0
$0.27 P/Share
|
|
Aug 19
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-3.11%
|
$0
$0.3 P/Share
|
|
Aug 18
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-3.02%
|
$0
$0.34 P/Share
|
|
Aug 14
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.93%
|
$0
$0.31 P/Share
|
|
Aug 03
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
70,000
-3.94%
|
$0
$0.32 P/Share
|
|
Jul 31
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
5,000
-0.28%
|
$0
$0.34 P/Share
|
|
Jul 30
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
25,000
-1.38%
|
$0
$0.32 P/Share
|
|
Jul 21
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.69%
|
$0
$0.45 P/Share
|
|
Jul 20
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
150,000
-7.48%
|
$0
$0.43 P/Share
|
|
Jul 18
2020
|
Matthew Jenusaitis Director |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Jul 17
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.43%
|
$0
$0.38 P/Share
|
|
Jul 16
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.37%
|
$0
$0.38 P/Share
|
|
Jul 06
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
6,450
-0.31%
|
$0
$0.39 P/Share
|
|
Jul 02
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
57,000
-2.63%
|
$0
$0.4 P/Share
|
|
Jul 01
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
45,000
-2.03%
|
$0
$0.38 P/Share
|